Compare
Andersen Group Inc. vs XBP Global Holdings, Inc. vs Nutex Health Inc. vs ACV Auctions Inc.
| Latest fiscal year | Andersen Group Inc. ANDG | XBP Global Holdings, Inc. XBPLast annual report: year ended 2024-12-31 | Nutex Health Inc. NUTX | ACV Auctions Inc. ACVA |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2024-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $838.69M | $872.69M | $875.26M | $759.61M |
| Revenue growth (YoY) | +14.6% | n/a | +82.4% | +19.2% |
| Gross margin | n/a | 21.6% | 50.8% | n/a |
| Operating margin | -16.1% | -12.1% | 31.5% | -8.3% |
| Net margin | -15.5% | -24.7% | 8.1% | -8.7% |
| Net income | -$130.17M | -$215.15M | $70.79M | -$66.14M |
| EPS (Diluted) | n/a | $0.41 | $10.48 | -$0.39 |
| Operating cash flow | $184.62M | $23.27M | $248.12M | $78.23M |
| Free cash flow | $174.27M | $16.97M | $245.60M | $69.13M |
| Cash & equivalents | $250.28M | $11.63M | $185.57M | $271.50M |
| Total assets | $565.14M | $390.42M | $918.52M | $1.09B |
| Total liabilities | $593.52M | $1.85B | $495.09M | $655.93M |
| Shareholders' equity | -$134.73M | -$1.46B | $423.44M | $429.68M |
| Return on year-end equity | n/a | n/a | 16.7% | -15.4% |
| Shares outstanding | n/a | 30.17M | 7.09M | n/a |
Revenue, most recent five fiscal years
| Fiscal year | Andersen Group Inc. | XBP Global Holdings, Inc. | Nutex Health Inc. | ACV Auctions Inc. |
|---|---|---|---|---|
| Latest | $838.69M Ended 2025-12-31 | $872.69M Ended 2024-12-31 | $875.26M Ended 2025-12-31 | $759.61M Ended 2025-12-31 |
| 1 year earlier | $731.59M Ended 2024-12-31 | n/a | $479.95M Ended 2024-12-31 | $637.16M Ended 2024-12-31 |
| 2 years earlier | $639.11M Ended 2023-12-31 | n/a | $247.65M Ended 2023-12-31 | $481.23M Ended 2023-12-31 |
| 3 years earlier | n/a | n/a | $219.29M Ended 2022-12-31 | $421.53M Ended 2022-12-31 |
| 4 years earlier | n/a | n/a | $331.53M Ended 2021-12-31 | $358.44M Ended 2021-12-31 |